Marije Slingerland

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken et al. · The Lancet Oncology · 2018 · 576 citations

Medicine, Oncology, Surgery +17

Androgen deprivation therapy for androgen receptor‐positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands

Eline Boon, Wim van Boxtel, Jan Buter et al. · Head & Neck · 2017 · 115 citations · Full text

Medicine, Oncology, Oral Oncology +8

Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation

Maja J.A. de Jonge, Marije Slingerland, Walter J. Loos et al. · European Journal of Cancer · 2010 · 90 citations

Pharmacy, Oncology, Pharmacology +14

Bioequivalence of Liposome-Entrapped Paclitaxel Easy-To-Use (LEP-ETU) Formulation and Paclitaxel in Polyethoxylated Castor Oil: A Randomized, Two-Period Crossover Study in Patients With Advanced Cancer

Marije Slingerland, Henk‐Jan Guchelaar, Hilde Rosing et al. · Clinical Therapeutics · 2013 · 88 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative

Robert R.J. Coebergh van den Braak, L. Bengt van Rijssen, Jessy Joy van Kleef et al. · Acta Oncologica · 2017 · 83 citations · Full text

Medicine, Oncology, Gastroenterology +16